Stelara Sales Data
| Rank 54 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Stelara U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 54 ( 8) |
$270,598 | 12.47% | 30 | 11.11% |
| Q3 2013 | 62 (6) |
$240,598 | 7.67% | 27 | 3.85% |
| Q2 2013 | 68 (13) |
$223,466 | 10.65% | 26 | 8.33% |
| Q1 2013 | 81 (12) |
$201,950 | 10.71% | 24 | 4.35% |
| Q4 2012 | 93 (7) |
$182,409 | 7.52% | 23 | 4.55% |
| Q3 2012 | 100 ( ) |
$169,648 | n/a | 22 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
